Study shows hepatitis C treatment can be shortened
Burman’s Specialty Pharmacy recently announced study findings that showed more than 25 percent of hepatitis C patients may be treated with an eight-week therapy — four weeks shorter than drug manufacturers first believed. Read More »
Alerts Sign-up